These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27860440)

  • 1. Integrating Clinical Phenotype and Gene Expression Data to Prioritize Novel Drug Uses.
    Paik H; Chen B; Sirota M; Hadley D; Butte AJ
    CPT Pharmacometrics Syst Pharmacol; 2016 Nov; 5(11):599-607. PubMed ID: 27860440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network.
    Jadamba E; Shin M
    Biomed Res Int; 2016; 2016():7147039. PubMed ID: 28127549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic drug repositioning for a wide range of diseases with integrative analyses of phenotypic and molecular data.
    Iwata H; Sawada R; Mizutani S; Yamanishi Y
    J Chem Inf Model; 2015 Feb; 55(2):446-59. PubMed ID: 25602292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug repurposing based on drug-drug interaction.
    Zhou B; Wang R; Wu P; Kong DX
    Chem Biol Drug Des; 2015 Feb; 85(2):137-44. PubMed ID: 24934184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.
    Tan F; Yang R; Xu X; Chen X; Wang Y; Ma H; Liu X; Wu X; Chen Y; Liu L; Jia X
    Mol Biosyst; 2014 May; 10(5):1126-38. PubMed ID: 24603772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Literature-based prediction of novel drug indications considering relationships between entities.
    Jang G; Lee T; Lee BM; Yoon Y
    Mol Biosyst; 2017 Jun; 13(7):1399-1405. PubMed ID: 28581007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated network platform for contextual prioritization of drugs and pathways.
    Segura-Cabrera A; Singh N; Komurov K
    Mol Biosyst; 2015 Nov; 11(11):2850-9. PubMed ID: 26315485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of drug gene associations via ontological profile similarity with application to drug repositioning.
    Kissa M; Tsatsaronis G; Schroeder M
    Methods; 2015 Mar; 74():71-82. PubMed ID: 25498216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A two-tiered unsupervised clustering approach for drug repositioning through heterogeneous data integration.
    Hameed PN; Verspoor K; Kusljic S; Halgamuge S
    BMC Bioinformatics; 2018 Apr; 19(1):129. PubMed ID: 29642848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inferring new drug indications using the complementarity between clinical disease signatures and drug effects.
    Jang D; Lee S; Lee J; Kim K; Lee D
    J Biomed Inform; 2016 Feb; 59():248-57. PubMed ID: 26707452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix Factorization-Based Prediction of Novel Drug Indications by Integrating Genomic Space.
    Dai W; Liu X; Gao Y; Chen L; Song J; Chen D; Gao K; Jiang Y; Yang Y; Chen J; Lu P
    Comput Math Methods Med; 2015; 2015():275045. PubMed ID: 26078775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Performance of Gene Expression Signature-Guided Drug-Disease Association in Different Categories of Drugs and Diseases.
    Qi X; Shen M; Fan P; Guo X; Wang T; Feng N; Zhang M; Sweet RA; Kirisci L; Wang L
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32560162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DeSigN: connecting gene expression with therapeutics for drug repurposing and development.
    Lee BK; Tiong KH; Chang JK; Liew CS; Abdul Rahman ZA; Tan AC; Khang TF; Cheong SC
    BMC Genomics; 2017 Jan; 18(Suppl 1):934. PubMed ID: 28198666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico drug repositioning: from large-scale transcriptome data to therapeutics.
    Kwon OS; Kim W; Cha HJ; Lee H
    Arch Pharm Res; 2019 Oct; 42(10):879-889. PubMed ID: 31482491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of drug indications based on chemical interactions and chemical similarities.
    Huang G; Lu Y; Lu C; Zheng M; Cai YD
    Biomed Res Int; 2015; 2015():584546. PubMed ID: 25821813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing the use of genome-wide association studies for drug repurposing.
    Reay WR; Cairns MJ
    Nat Rev Genet; 2021 Oct; 22(10):658-671. PubMed ID: 34302145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Novel Drugs for Hepatocellular Carcinoma Based on Multi-Source Random Walk.
    Yu L; Su R; Wang B; Zhang L; Zou Y; Zhang J; Gao L
    IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(4):966-977. PubMed ID: 27076463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network-based drug ranking and repositioning with respect to DrugBank therapeutic categories.
    Re M; Valentini G
    IEEE/ACM Trans Comput Biol Bioinform; 2013; 10(6):1359-71. PubMed ID: 24407295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the associations between drug side-effects and therapeutic indications.
    Wang F; Zhang P; Cao N; Hu J; Sorrentino R
    J Biomed Inform; 2014 Oct; 51():15-23. PubMed ID: 24727480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.